Wednesday, June 26, 2013

THE UNIVERSITY OF PENNSYLVANIA HAS LAUNCHED THE CD19 TRIAL
"ADOPTIVE IMMUNOTHERAPY FOR CHEMOTHERAPY RESISTANT OR REFRACTORY CD19+ LEUKEMIA AND LYMPHOMA"
THEY ARE STUDYING CTL-O19, "AN AGENT COMPRISED OF AUTOLOGOUS T CELLS ENGINEERED  TO EXPRESS AN ANTIBODY AGAINST CD19"

CALL DR NOELLE FREY AND  DAVID PORTER AT 215-662-2867 TO REFER PATIENTS!
Post a Comment